No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Apollomics Shares Are Trading Lower. The Company Reported FY24 Financial Results.
20-F: FY2024 Annual Report
6-K: Report of foreign private issuer (related to financial reporting)
Apollomics FY24 Loss/Shr $52.80 >APLM
Apollomics Signs Exclusive Development, Commercialization Deal for Vebreltinib in Asia
12 Health Care Stocks Moving In Monday's Pre-Market Session